MARKET

AMRX

AMRX

Amneal Pharmaceuticals Inc
NASDAQ
12.60
-0.28
-2.17%
After Hours: 12.56 -0.04 -0.32% 19:27 12/31 EST
OPEN
12.85
PREV CLOSE
12.88
HIGH
12.92
LOW
12.59
VOLUME
1.63M
TURNOVER
--
52 WEEK HIGH
13.01
52 WEEK LOW
6.69
MARKET CAP
3.96B
P/E (TTM)
763.64
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AMRX last week (1222-1226)?
Weekly Report · 12/29/2025 10:15
Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA
NASDAQ · 12/23/2025 05:49
Amneal, mAbxience Get FDA Approval For Two Biosimilars
Dow Jones · 12/22/2025 21:14
Amneal Pharmaceuticals announces FDA approval for Boncresa, Oziltus BLAs
TipRanks · 12/22/2025 21:05
Amneal Pharmaceuticals Gets FDA's Approval For Biologics Licensing Applications For Boncresa, Oziltus
Benzinga · 12/22/2025 21:02
AMNEAL PHARMA - EXPECTS TO COMMERCIALIZE SIX BIOSIMILARS BY 2027
Reuters · 12/22/2025 21:01
AMNEAL ANNOUNCES FDA APPROVAL OF DENOSUMAB BIOSIMILARS REFERENCING PROLIA® AND XGEVA®
Reuters · 12/22/2025 21:01
FDA Approves Amneal and mAbxience Denosumab Biosimilars
Reuters · 12/22/2025 21:00
More
About AMRX
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Webull offers Amneal Pharmaceuticals Inc stock information, including NASDAQ: AMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRX stock methods without spending real money on the virtual paper trading platform.